SCHEMBL25639311

SCHEMBL25639311

CCc1ccnc(CC(C)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS3 P29474 2/20 0.48
▸ NOS1 P29475 2/20 0.48
▸ NOS2 P35228 2/20 0.48
▸ CYP1A2 P05177 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ AAK1 Q2M2I8 2/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ DBF4 Q9UBU7 1/20 0.33
▸ LOXL2 Q9Y4K0 1/20 0.32
▸ SMYD3 Q9H7B4 1/20 0.32
▸ TRPA1 O75762 1/20 0.31
▸ RIOK2 Q9BVS4 1/20 0.31
▸ SREBF1 P36956 1/20 0.31
▸ SREBF2 Q12772 1/20 0.31
▸ LMNA P02545 2/20 0.31
▸ NPC1 O15118 2/20 0.31
▸ RAB9A P51151 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20207667 0.85 NOS3 (0.52) NOS3NOS1NOS2CYP1A2POLB
SCHEMBL218290 0.82 NOS3 (0.61) NOS3NOS1NOS2CYP1A2POLB
SCHEMBL11563922 0.80 NOS3 (0.59) NOS3NOS1NOS2CYP1A2POLB
SCHEMBL17000195 0.77 POLB (0.44) NOS3NOS1NOS2CYP1A2POLB
SCHEMBL16976310 0.76 NOS3 (0.55) NOS3NOS1NOS2CYP1A2POLB
Dimethylamine SCHEMBL7744073 0.76 NOS3 (0.55) NOS3NOS1NOS2CYP1A2POLB
SCHEMBL26192789 0.76 NOS3 (0.50) NOS3NOS1NOS2CYP1A2POLB
SCHEMBL23986930 0.74 NOS3 (0.41) NOS3NOS1NOS2CYP1A2POLB
SCHEMBL17778607 0.73 NOS3 (0.52) NOS3NOS1NOS2AAK1LOXL2
SCHEMBL14470239 0.72 NOS3 (0.55) NOS3NOS1NOS2CYP1A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091554-A1 NOVEL HETEROARYL-UREA COMPOUNDS AS KV7.2 INHIBITORS ICAGEN, LLC (US) 2023-05-25 — — WO disclosed
Send feedback